There are approximately 20 clinical trials underway by ENT and Allergy physicians. Here is a sample of what we are doing:
The purpose of this research study is to evaluate an experimental blood test to help doctors know when symptoms associated with COPD are becoming worse. Patients with breathing problems that are not COPD will also be enrolled. Experimental tests, such as those used on the blood collected in this study are also known as "investigational." This means the tests have not been approved by the U.S. Food and Drug Administration (FDA). In this study, the accuracy of these blood tests will be determined by comparing the results with other tests as determined by your study doctor.
Patients who experience food, seasonal and/or perennial allergy and asthma symptoms can contact us to discuss inclusion criteria for one of our allergy trials. We are recruiting for both pediatric and adult trials. Some of the current allergy trials include cow’s milk allergy, new cat peptide immunotherapy, chronic urticaria and a new inhaler for treatment of chronic persistent asthma.
Since the discovery of a new meat allergy was identified in regions of the country endemic with ticks, many of the allergists have been busy testing and treating patients for this condition. One of our allergists, Dr Erin McGintee, is working with researchers at The University of Virginia School of Medicine gathering data for a large multi-center case series report to increase awareness of a typical signs and symptoms of tick borne illnesses. Patients with suspected alpha-gal allergy should contact our Clinical Research team for referral to one of our allergy specialists.
The Clinical Research Division administrative office is located at 103 Executive Drive, 3rd Floor, Suite 500, New Windsor, NY 12553. The research itself takes place throughout many of our different locations. The Clinical Research Team can be reached Monday - Friday from 9:00 - 5:00, and our direct phone number is 845-562-5941. Or, contact us via email: SDonovan@entandallergy.com
We have a topical antibiotic clinical trial enrolling candidates needing ear tubes. This study involves administration of a FDA approved topical antibiotic post surgically.
Patient recruitment is underway for a randomized clinical study of safety and efficacy of balloon dilation procedure for adults with chronic Eustachian Tube Dysfunction.
Research into throat/neck pain with phonation, known as odynophonia, is lacking. We are conducting a retrospective study to determine whether correlations exists between the presence and type of laryngeal pathology with odynophonia, sidedness of the pain with the particular laryngeal pathology and between improvement in laryngeal pathology and improvement in the odynophonia.
Dr. Ofer Jacobowitz is investigating a new device for patients with Obstructive Sleep Apnea. This phase 2 study is collecting data to determine the safety and efficacy of a hypoglossal nerve stimulator. Qualified individuals have a diagnosis of Obstructive Sleep Apnea and have not received lasting benefit from CPAP or other treatments. This device is designed to reduce or eliminate sleep apnea episodes.
ENTA is currently seeking participants for a clinical research study evaluating the safety and effectiveness of the investigational dilation system for frontal and sphenoid sinus treatment.
Phase 3 clinical trial for new topical medication to treat acute onset tinnitus. The tinnitus can be the result of any acute traumatic event such as head trauma, noise exposure, barotrauma, middle ear infection.